Cardiac myxoma in its morphology is a typical benign tumor, meanwhile, the fact of its localization in the heart chamber, directly in the constant blood flow, largely determines the clinical behavior of this neoplasm, which is often manifested by the development of characteristics that formally determine the aggressive and even malignant nature of the course. Accordingly, the malignancy of cardiac myxoma is determined more by its clinical behavior (recurrence, multifocality of the lesion, the presence of mechanisms of spread similar to metastasis) rather than by its histological picture. In the structure of primary benign tumors of the heart, myxoma occupies a dominant position and its incidence is up to 85%. According to some authors, the tumor develops from multipotent mesenchymal stem cells of the endocardium, mainly in the area of the fossa ovale, while according to others the histogenesis of the tumor remains unclear. The obligate morphology element is the myxoma cell. The presence of so-called “ring” structures is special, regular and highly specific, and Gamna — Gandy bodies, foci of calcification and superficial thrombosis are considered characteristic secondary destructive morphological signs. The review describes the morphology features, specific clinical manifestations, immunohistochemical parameters of cardiac myxoma, and presents information available in the literature on the mechanisms of tumor spread (metastasis).
Primary diffuse leptomeningeal melanocytosis (PDLM) is a rare neoplastic lesion of the central nervous system, characterized by diffuse infiltration of the leptomeninges by melanocytes without apparent invasion into the brain parenchyma. Diagnosing the disease is challenging due to its nonspecific clinical presentation and the lack of clear neuroimaging criteria, necessitating morphological and immunohistochemical studies for definitive verification.This article presents a clinical case of a patient with progressive neurological impairments, diagnostic challenges, and postmortem verification of PDLM. The key differential diagnostic aspects, the morphological structure of the tumor, and its immunohistochemical profile are described. Additionally, neuroimaging data are provided, demonstrating characteristic changes associated with PDLM. The presented clinical case highlights the necessity of a multidisciplinary approach to managing patients with chronic meningeal lesions of unknown etiology and underscores the importance of further research in molecular diagnostics and potential treatment strategies.
This lecture presents current data on the role of regulatory proteins of epithelial-mesenchymal transition (EMT) in colorectal cancer (CRC) in the context of tumor molecular stratification and personalized treatment selection. EMT is a key biological process associated with tumor invasion, metastasis, chemoresistance, and immune evasion. Special attention is given to the characterization of CRC molecular subtypes according to the Consensus Molecular Subtypes (CMS) classification, particularly the CMS4 subtype with mesenchymal features, which is marked by high EMT activity and poor prognosis. The lecture discusses molecular and immunohistochemical markers indicative of EMT activation, including CDX2, ZEB1, HTR2B, FRMD6, BMI-1, and ROR1. The expression patterns and associated signaling pathways of these proteins are examined along with their influence on tumor aggressiveness, therapy resistance, and prospects for clinical application. Based on the literature analysis, the potential of these proteins as prognostic and possibly predictive biomarkers, as well as therapeutic targets, is discussed.
Most intracranial arachnoid cysts are thought to be non-tumorous, congenital, intra-arachnoid cerebrospinal fluid collections that account for about 1% of all intracranial space-occupying lesions. In children, the prevalence of this pathology is 2.6%; in adults, it reaches 1.4%. The disease is more often registered in men. Most often arachnoid cysts are supratentorial. Their most common locations are in the middle cranial fossa and the retrocerebellar cistern. Less often they can be detected on the convexity of the brain hemispheres; however, cases of arachnoid cysts at more unusual sites have also been described, including in newborns. The pathology is often characterized by an asymptomatic course, while certain symptoms may have an acute onset, which is due to compression of brain structures caused by the large cyst size.This article describes a clinical case of a large intracranial arachnoid cyst in a 28-year-old man. It was not verified in the antemortem diagnosis, but was revealed according to the autopsy findings (macroscopic features of the cyst, histologic presentation with specific morphological changes, and findings of computed tomography of the cerebral hemispheres).